National Academies Press: OpenBook

Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System: Interim Report (2009)

Chapter: Appendix A Agendas for Data-Gathering Sessions Open to the Public

« Previous: Interim Report
Suggested Citation:"Appendix A Agendas for Data-Gathering Sessions Open to the Public." Institute of Medicine and National Research Council. 2009. Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/12599.
×
Page 7
Suggested Citation:"Appendix A Agendas for Data-Gathering Sessions Open to the Public." Institute of Medicine and National Research Council. 2009. Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/12599.
×
Page 8
Suggested Citation:"Appendix A Agendas for Data-Gathering Sessions Open to the Public." Institute of Medicine and National Research Council. 2009. Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/12599.
×
Page 9
Suggested Citation:"Appendix A Agendas for Data-Gathering Sessions Open to the Public." Institute of Medicine and National Research Council. 2009. Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/12599.
×
Page 10

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix A Agendas for Data-Gathering Sessions Open to the Public Meeting 1 July 30–31, 2008 The Keck Center of the National Academies 500 Fifth Street, N.W. Washington, DC Wednesday, July 30, 2008 1:00 p.m. Introductory remarks Bernard Goldstein, M.D., Chair Committee on Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System Introductions by committee members and meeting attendees 1:15 Study Context and Goals: Congressional Perspective Representative David Price (D-N.C.) Chairman, Homeland Security Subcommittee of the House Appropriations Committee Discussion 1:45 Study Context and Goals: Sponsor Perspective Jeffrey Runge, M.D. Assistant Secretary and Chief Medical Officer Department of Homeland Security Discussion 2:15 Introduction to the BioWatch Program and Its Technology Robert Hooks Deputy Assistant Secretary for WMD and Biodefense 7

8 EFFECTIVENESS OF NATIONAL BIOSURVEILLANCE SYSTEM Office of Health Affairs Department of Homeland Security Discussion 3:00 Introduction to Public Health Surveillance Activities at the Federal Level: Public Health Information Network (PHIN), BioSense, and Related Surveillance Tools Daniel Sosin, M.D. Coordinating Office for Terrorism Preparedness and Emergency Response Centers for Disease Control and Prevention Discussion 3:45 DoD Pentagon Shield Paul Benda Director, CBRNE Directorate Pentagon Force Protection Agency Discussion 4:30 Introduction to the GAO Review of Biosurveillance Across the Federal Government William O. Jenkins, Jr. Director, Homeland Security and Justice U.S. Government Accountability Office (GAO) Discussion 5:00 Adjourn Open Session Meeting 2 September 22–24, 2008 Conference Center, Venable LLP 575 Seventh Street, N.W. Washington, DC Monday, September 22, 2008 4:30–5:00 p.m. Intersection of Environmental Detection and Public Health Surveillance Michael Osterholm, Ph.D., M.P.H. Center for Infectious Disease Research and Policy, University of Minnesota Tuesday, September 23, 2008 9:15 a.m. Introductory remarks Bernard Goldstein, M.D., Chair Joseph DeSimone, Ph.D., Vice Chair

APPENDIX A 9 Introductions by committee members and meeting attendees 9:30–11:00 Panel: Perspectives on BioWatch Detection Events: Experience and Lessons Learned Session Moderator: Marci Layton Chevelle Glymph, M.P.H., District of Columbia Department of Health Denise Sockwell, M.S.P.H., Virginia Department of Health Debora Boyle, D.V.M., Ph.D., Center for Infectious Disease Research and Policy, University of Minnesota Pamela Diaz, M.D., Centers for Disease Control and Prevention 11:00–12:30 Panel: Surveillance in Public Health and Health Care Session Moderator: Jim Buehler Atar Baer, Ph.D., Public Health, Seattle-King County, WA [by phone] Joe Gibson, Ph.D., Marion County Health Department, IN [by phone] Alana Deyneka, M.D., North Carolina Division of Public Health Richard S. Hopkins, M.D., M.S.P.H., Florida Department of Health Jerry Tokars, M.D., M.P.H., Centers for Disease Control and Prevention David Buckeridge, M.D., Ph.D., McGill University 12:30 p.m. Working Lunch 1:30–3:00 Panel: Laboratory Roles in BioWatch and Surveillance in Public Health and Health Care Session Moderator: Norman Crouch Vickie Baselski, Ph.D., University of Tennessee Hawazin Faruki, Dr.P.H., Laboratory Corporation of America Mary Gilchrist, Ph.D., Massachusetts Department of Public Health Harvey Holmes, Ph.D., Centers for Disease Control and Prevention Sudha Pottumarthy, Ph.D., Houston Public Health Laboratory [by phone] Mary Shaffran, M.P.A., Association of Public Health Laboratories Meeting 3 November 3–5, 2008 The Keck Center of the National Academies 500 Fifth Street, N.W. Washington, DC Monday, November 3, 2008 9:20 a.m. Introductory remarks Bernard Goldstein, Chair Joseph DeSimone, Vice Chair Introductions by committee members and meeting attendees 9:30 a.m. Thoughts on Biosurveillance Tara O’Toole, M.D., M.P.H. CEO and Director

10 EFFECTIVENESS OF NATIONAL BIOSURVEILLANCE SYSTEM Center for Biosecurity of the University of Pittsburgh Medical Center 10:15–12:15 Panel: Critical Information Needs for Decision Makers Moderator: Calvin Johnson James Hadler, M.D., M.P.H., New Haven, Connecticut Jeffrey Engel, M.D., North Carolina State Epidemiologist Herminia Palacio, M.D., M.P.H., Harris County Public Health and Environmental Services, Texas Martin Fenstersheib, M.D., M.P.H., Santa Clara County Health Department, California [by phone] 12:15 p.m. Working Lunch 12:45–1:15 Amy Altman, Ph.D. Director, Extramural Research Office Luminex Corporation 1:15–3:00 Panel: Index Case Recognition: Current Realities/Future Opportunities Moderator: Art Kellermann Kate Heilpern, M.D., Emory University Michael Bullard, M.D., University of Alberta, Edmonton Art Papier, M.D., Logical Images, Inc. Barry Rhodes, Ph.D., National Center for Public Health Informatics, CDC 3:15–5:00 Panel: Point-of-Care Diagnostics: Current Realities/Future Opportunities Moderator: Jerome Schultz Stephen Quake, D.Phil., Stanford [by phone] Frances Ligler, D.Phil., D.Sc., Naval Research Laboratory Gerald Kost, M.D., Ph.D., UC Davis and Lawrence Livermore National Laboratory Amy Altman, Ph.D., Luminex Corporation 5:00 p.m. Adjourn Open Session Tuesday, November 4, 2008 1:45–3:15 p.m. Other Operational Approaches to Environmental Monitoring for Bioterrorism 1:45 DoD Joint Program Guardian Installation Protection Program COL Mark Malatesta Joint Project Manager–Guardian Joint Program Executive Office for Chemical and Biological Defense, DoD 2:30 Postal Service Biohazard Detection System Patrick Mendonca Senior Director, Policy and Planning U.S. Postal Service 3:15 Adjourn Open Session

Next: Appendix B Biographical Sketches of Committee Members »
Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System: Interim Report Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

For many years, concerns about bioterrorism and emerging infectious diseases have drawn attention to the need for strong surveillance systems. Experts are working to develop new and better ways to detect these biological threats as quickly as possible. One effort in this area is the Department of Homeland Security's BioWatch program.

To evaluate the effectiveness of the BioWatch program, the Institute of Medicine (IOM) and National Research Council (NRC) convened the Committee on Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System. This interim report contains no findings and recommendations, but outlines the committee's initial progress.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!